FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3021805716> ?p ?o ?g. }

• W3021805716 abstract "Dihydroartemisinin (DHA), a derivate of artemisinin, is an effective antimalarial agent. DHA has been shown to exert anticancer activities to numerous cancer cells in the past few years, while the exact molecular mechanisms remain to be elucidated, especially in esophageal cancer.Crystal violet assay was conducted to determine the cell viability of human esophageal cancer cell line Eca109 treated with DHA. Tumor-bearing nude mice were employed to evaluate the anticancer effect of DHA in vivo. Soft agar and crystal violet assays were used to measure the tumorigenicity of Eca109 cells. Flow cytometry was performed to evaluate ROS or cell cycle distribution. GFP-LC3 plasmids were delivered into Eca109 cells to visualize autophagy induced by DHA under a fluorescence microscope. The mRNA and protein levels of each gene were tested by qRT-PCR and western blot, respectively.Our results proved that DHA significantly reduced the viability of Eca109 cells in a dose- and time-dependent manner. Further investigation showed that DHA evidently induced cell cycle arrest at the G2/M phase in Eca109 cells. Mechanistically, DHA induced intracellular ROS generation and autophagy in Eca109 cells, while blocking ROS by an antioxidant NAC obviously inhibited autophagy. Furthermore, we found that telomere shelterin component TRF2 was down-regulated in Eca109 cells exposed to DHA through autophagy-dependent degradation, which could be rescued after autophagy was blocked by ROS inhibition. Moreover, the DNA damage response (DDR) was induced obviously in DHA treated cells. To further explore whether ROS or autophagy played a vital role in DHA induced cell cycle arrest, the cell cycle distribution of Eca109 cells was evaluated after ROS or autophagy blocking, and the results showed that autophagy, but not ROS, was essential for cell cycle arrest in DHA treated cells.Taken together, DHA showed anticancer effect on esophageal cancer cells through autophagy-dependent cell cycle arrest at the G2/M phase, which unveiled a novel mechanism of DHA as a chemotherapeutic agent, and the degradation of TRF2 followed by DDR might be responsible for this cell phenotype." @default.
• W3021805716 created "2020-05-13" @default.
• W3021805716 creator A5009613920 @default.
• W3021805716 creator A5011605756 @default.
• W3021805716 creator A5019224827 @default.
• W3021805716 creator A5034623547 @default.
• W3021805716 creator A5044044650 @default.
• W3021805716 creator A5045027467 @default.
• W3021805716 creator A5052241021 @default.
• W3021805716 creator A5056469533 @default.
• W3021805716 creator A5060980269 @default.
• W3021805716 creator A5077702516 @default.
• W3021805716 creator A5080904358 @default.
• W3021805716 creator A5085355247 @default.
• W3021805716 creator A5086408011 @default.
• W3021805716 creator A5087511909 @default.
• W3021805716 creator A5087637921 @default.
• W3021805716 date "2020-04-25" @default.
• W3021805716 modified "2023-10-09" @default.
• W3021805716 title "Autophagy-dependent cell cycle arrest in esophageal cancer cells exposed to dihydroartemisinin" @default.
• W3021805716 cites W1974560134 @default.
• W3021805716 cites W1985323404 @default.
• W3021805716 cites W1991156963 @default.
• W3021805716 cites W2016468663 @default.
• W3021805716 cites W2017641061 @default.
• W3021805716 cites W2034339677 @default.
• W3021805716 cites W2039607936 @default.
• W3021805716 cites W2125747506 @default.
• W3021805716 cites W2140912399 @default.
• W3021805716 cites W2160185049 @default.
• W3021805716 cites W2272984102 @default.
• W3021805716 cites W2312266417 @default.
• W3021805716 cites W2397307577 @default.
• W3021805716 cites W2404762861 @default.
• W3021805716 cites W2412110907 @default.
• W3021805716 cites W2473719221 @default.
• W3021805716 cites W2475286376 @default.
• W3021805716 cites W2554388458 @default.
• W3021805716 cites W2563470051 @default.
• W3021805716 cites W2573616138 @default.
• W3021805716 cites W2609425047 @default.
• W3021805716 cites W2614544018 @default.
• W3021805716 cites W2760001695 @default.
• W3021805716 cites W2760575658 @default.
• W3021805716 cites W2803613043 @default.
• W3021805716 cites W2888131559 @default.
• W3021805716 cites W2891588311 @default.
• W3021805716 cites W2891644187 @default.
• W3021805716 cites W2892711895 @default.
• W3021805716 cites W2896378665 @default.
• W3021805716 cites W2916132371 @default.
• W3021805716 cites W2936303124 @default.
• W3021805716 cites W2948028167 @default.
• W3021805716 cites W2956337587 @default.
• W3021805716 cites W2957653455 @default.
• W3021805716 cites W2958689031 @default.
• W3021805716 cites W2971366377 @default.
• W3021805716 cites W4211125721 @default.
• W3021805716 cites W2947143485 @default.
• W3021805716 doi "https://doi.org/10.1186/s13020-020-00318-w" @default.
• W3021805716 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7183693" @default.
• W3021805716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32351616" @default.
• W3021805716 hasPublicationYear "2020" @default.
• W3021805716 type Work @default.
• W3021805716 sameAs 3021805716 @default.
• W3021805716 citedByCount "16" @default.
• W3021805716 countsByYear W30218057162020 @default.
• W3021805716 countsByYear W30218057162021 @default.
• W3021805716 countsByYear W30218057162022 @default.
• W3021805716 countsByYear W30218057162023 @default.
• W3021805716 crossrefType "journal-article" @default.
• W3021805716 hasAuthorship W3021805716A5009613920 @default.
• W3021805716 hasAuthorship W3021805716A5011605756 @default.
• W3021805716 hasAuthorship W3021805716A5019224827 @default.
• W3021805716 hasAuthorship W3021805716A5034623547 @default.
• W3021805716 hasAuthorship W3021805716A5044044650 @default.
• W3021805716 hasAuthorship W3021805716A5045027467 @default.
• W3021805716 hasAuthorship W3021805716A5052241021 @default.
• W3021805716 hasAuthorship W3021805716A5056469533 @default.
• W3021805716 hasAuthorship W3021805716A5060980269 @default.
• W3021805716 hasAuthorship W3021805716A5077702516 @default.
• W3021805716 hasAuthorship W3021805716A5080904358 @default.
• W3021805716 hasAuthorship W3021805716A5085355247 @default.
• W3021805716 hasAuthorship W3021805716A5086408011 @default.
• W3021805716 hasAuthorship W3021805716A5087511909 @default.
• W3021805716 hasAuthorship W3021805716A5087637921 @default.
• W3021805716 hasBestOaLocation W30218057161 @default.
• W3021805716 hasConcept C105696609 @default.
• W3021805716 hasConcept C121608353 @default.
• W3021805716 hasConcept C153911025 @default.
• W3021805716 hasConcept C185592680 @default.
• W3021805716 hasConcept C190283241 @default.
• W3021805716 hasConcept C203014093 @default.
• W3021805716 hasConcept C203522944 @default.
• W3021805716 hasConcept C2776120307 @default.
• W3021805716 hasConcept C2778048844 @default.
• W3021805716 hasConcept C2778371730 @default.
• W3021805716 hasConcept C2781160685 @default.
• W3021805716 hasConcept C29537977 @default.
• W3021805716 hasConcept C53227056 @default.

• next